Проблема системного кандидоза после трансплантации солидных органов. Обзор литературы
https://doi.org/10.23873/2074-0506-2012-0-3-42-48
Аннотация
Описаны современные взгляды на эпидемиологию, диагностику и лечение кандидоза при трансплантации органов.
Об авторах
С. В. Журавель
НИИ СП им. Н.В. Склифосовского
Россия
Сергей Владимирович Журавель
Россия
Сергей Владимирович Журавель
А. О. Чугунов
НИИ СП им. Н.В. Склифосовского
Россия
Россия
Т. В. Черненькая
НИИ СП им. Н.В. Склифосовского
Россия
Россия
Список литературы
1. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET) / P.G. Pappas [et al.] // Clin. Infect. Dis. – 2010. – Vol. 50 (8). –P. 1101–1111.
2. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients / D. Neofytos [et al.] // Transplant. Infect. Dis. – 2010. – Vol. 12 (3). –P. 220–229.
3. Invasive non-aspergillus mold infections in transplant recipients, United States 2001–2006 / B. J. Park [et al.] // Emerg. Infect. Dis. – 2011. – Vol. 17 (10). – P. 1855–1864.
4. Fishman, J.A. Infection in solid-organ transplant recipients / J.A. Fishman // N. Engl. J. Med. – 2007. – Vol. 357 (25). – P. 2601–2614.
5. Donor-derived disease transmission events in the United States: data reviewed by the OPTN / UNOS disease transmission advisory committee / M.G. Ison [et al.] // Am. J. Transplant. – 2009. – Vol. 9 (8). – P. 1929–1935.
6. Donor-related coccidioidomycosis in organ transplant recipients / P.W. Wright [et al.] // Clin. Infect. Dis. – 2003. – Vol. 37 (9). – P. 1265–1269.
7. Wong, S.Y. Transmission of disseminated histoplasmosis via cadaveric renal transplantation: case report / S.Y. Wong, D.M. Allen // Clin. Infect. Dis. – 1992. – Vol. 14 (1). – P. 232–234.
8. Donor-derived aspergillosis from use of a solid organ recipient as a multiorgan donor / N.J. Mueller [et al.] // Transplant. Infect. Dis. – 2010. –Vol. 12 (1). – P. 54–59.
9. Posttransplantation disseminated coccidioidomycosis acquired from donor lungs / M. B. Miller [et al.] // J. Clin. Microbiol. – 2004. – Vol. 42 (5). – P. 2347–2349.
10. Transmission of tropical and geographically restricted infections during solid-organ transplantation / P. MartinDavila [et al.] // Clin. Microbiol. Rev. – 2008. – Vol. 21 (1). – P. 60–96.
11. Transmission of histoplasma capsulatum by organ transplantation / A.P. Limaye [et al.] // N. Engl. J. Med. – 2000. – Vol. 343 (16). – P. 1163–1166.
12. Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients / M.R. Keating [et al.] // Chest. – 1996. – Vol. 109 (4). – P. 1119–1124.
13. Fungal infections in lung and heartlung transplant recipients: Report of 9 cases and review of the literature / S.S. Kanj [et al.] // Med. (Baltimore). – 1996. – Vol. 75 (3). – P. 142–156.
14. Grossi, P.A. Donor-derived infections in solid organ transplant recipients / P. A. Grossi, J. A. Fishman // Am. J. Transplant. – 2009. – Vol. 9 (Suppl. 4). – S. 19–26.
15. Fischer, S.A. Screening of donor and recipient prior to solid organ transplantation / S.A. Fischer, R.K. Avery // Am. J. Transplant. – 2009. – Vol. 9 (Suppl. 4). – S. 7–18.
16. Renal artery rupture secondary to pretransplantation Candida contamination of the graft in two different recipients / J. Calvino [et al.] // Am. J. Kidney Dis. – 1999. – Vol. 33 (1). – P. E3.
17. Transmission of Cryptococcus neoformans by organ transplantation / J.W. Baddley [et al.] // Clin. Infect. Dis. – 2011. – Vol. 52 (4). – P. E94 – E98.
18. Evidence that graft-site candidiasis after kidney transplantation is acquired during organ recovery: a multicenter study in France / L. Albano [et al.] // Clin. Infect. Dis. – 2009. – Vol. 48 (2). – P. 194–202.
19. Candida albicans arteritis transmitted by conservative liquid after renal transplantation: a report of four cases and review of the literature / H. Mai [et al.] // Transplantation. – 2006. – Vol. 82 (9) – P. 1163–1167.
20. Impact of bacterial and fungal donor organ contamination in lung, heart-lung, heart and liver transplantation / F. Mattner [et al.] // Infection. – 2008. – Vol. 36 (3). – P. 207–212.
21. Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience / S. J. Van Hal [et al.] // Transplant. Infect. Dis. – 2009. – Vol. 11 (2). – P. 122–127.
22. Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006 / S.R. Lockhart [et al.] // J. Clin. Microbiol. – 2011. – Vol. 49 (7). – P. 2404– 2410.
23. Molecular monitoring of Candida albicans infections in liver transplant recipients / A. Tavanti [et al.] // Eur. J. Clin. Microbiol. Infect. Dis. – 2001. – Vol. 20 (8). – P. 544–553.
24. Cecal colonization and systemic spread of Candida albicans in mice treated with antibiotics and dexamethasone / C.M. Bendel [et al.] // Pediatr. Res. – 2002. – Vol. 51 (3). – P. 290–295.
25. Candida spp. colonization significance in critically ill medical patients: a prospective study / P. E. Charles [et al.] // Intensive Care Med. – 2005. – Vol. 31 (3). – P. 393–400.
26. Bartholomew, G.A. Oral candidiasis in patients with diabetes mellitus: a thorough analysis / G.A. Bartholomew, B. Rodu, Bell D. S. // Diabetes Care. – 1987. – Vol. 10 (5). – P. 607–612.
27. Shoham, S. Invasive fungal infections in the ICU / S. Shoham, S. Marwaha // J. Intensive Care Med. – 2010. – Vol. 25 (2). – P. 78–92.
28. Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients / J. A. NietoRodriguez [et al.] // Ann. Surg. – 1996. – Vol. 223 (1). – P. 70–76.
29. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation / R. Patel [et al.] // Transplantation. – 1996. – Vol. 62 (7). – P. 926–934.
30. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study / S. Husain [et al.] // Transplantation. – 2003. – Vol. 75 (12). – P. 2023–2029.
31. Association of hepatic iron overload with invasive fungal infection in liver transplant recipients / J. Alexander [et al.] // Liver Transplant. – 2006. – Vol. 12 (12). – P. 1799–1804.
32. Incidence and outcome of fungal infections in pediatric small bowel transplant recipients / D.F. Florescu [et al.] // Transplant. Infect. Dis. – 2010. – Vol. 12 (6). – P. 497–504.
33. Early intra-abdominal infections associated with orthotopic liver transplantation / G. E. Reid [et al.] // Transplantation. – 2009. – Vol. 87 (11). – P. 1706–1711.
34. Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention / A. Said [et al.] // Am. J. Transplant. – 2004. – Vol. 4 (4). – P. 574–582.
35. Infected bilomas in liver transplant recipients: clinical features, optimal management, and risk factors for mortality / N. Safdar [et al.] // Clin. Infect. Dis. – 2004. – Vol. 39 (4). – P. 517–525.
36. Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials / M. Nucci [et al.] // Clin. Infect. Dis. – 2010. – Vol. 51 (3). – P. 295–303.
37. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis / T. Avni [et al.] // J. Clin. Microbiol. – 2011. – Vol. 49 (2). – P. 665–670.
38. 1,3–β-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid / M.A. Mennink-Kersten [et al.] // N. Engl. J. Med. – 2006. – Vol. 354 (26). – P. 2834–2835.
39. Invasive mycoses: diagnostic challenges / L. Ostrosky-Zeichner [et al.] // Am. J. Med. – 2012. – Vol. 125 (Suppl. 1). – S. 14 – 24.
40. Pseudomonas aeruginosa as a cause of 1,3-β-D-glucan assay reactivity / M.A. Mennink-Kersten [et al.] // Clin. Infect. Dis. – 2008. – Vol. 46 (12). – P. 1930–1931.
41. The (1,3) {β} -D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation / B. D. Alexander [et al.] // J. Clin. Microbiol. – 2010. – Vol. 48 (11). – P. 4083–4088.
42. Early diagnostic value of plasma PCT and BG assay for CRBSI after OLT / J. Chen [et al.] // Transplant. Proc. – 2011. – Vol. 43 (5). – P. 1777–1779.
43. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America / P.G. Pappas [et al.] // Clin. Infect. Dis. – 2009. – Vol. 48 (5). – P. 503–535.
44. Pappas, P.G. Candida in solid organ transplant recipients / P. G. Pappas, F. P. Silveira // Am. J. Transplant. – 2009. – Vol. 9 (Suppl. 4). – S. 173 – 179.
45. Anidulafungin versus Fluconazole for Invasive Candidiasis / C. Annette [et al.] // N. Engl. J. Med. – 2007. – Vol. 356. – P. 2472–2482.
46. Sorrell Echinocandin Antifungal Drugs in Fungal Infections A Comparison / C. A. Sharon [et al.] // Drugs. – 2011. – Vol. 71 (1). – P. 11–41.
47. Anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairment / J.A. Dowell [et al.] // J. Clin. Pharmacol. – 2007. – Vol. 47. – P. 461–470.
48. Aguado, J. M . S a f e t y o f Anidulafungin in Solid OrganTransplant Recipients / J. M. Aguado, E. Varo, P. Usetti // Liver Ttransplant. – 2012. – Vol. 18. – P. 680–685.
49. Safety and Pharmacokinetics of Multiple-Dose Anidulafungin in Infants and Neonates / Michael Cohen-Wolkowiez [et al.] // Clin. Pharmacol. Ther. – 2011. – Vol. 89 (5). – P. 702–707.
50. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole / M. A. Pfaller [et al.] // J. Clin. Microbiol. – 2005. – Vol. 43. – P. 5425–5427.
51. Mayr, M. Aigner and C. LassFl rl. Anidulafungin for the Treatment of Invasive Candidiasis // Clin. Microbiol. Infec. – 2011. – Vol. 17. – S. 1.
52. Kett1, D. H. Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis / D. H. Kett1, A. F. Shorr, A. C. Reboli // Critical Care. – 2011. – Vol. 15. – P. R253.
53. Ulmann, A. J. Guidelines for the treatment of invasive fungal infections: ESCMID Candida guidelines 2011 / 2012 / A.J. Ulmann // Mycoses. – 2011. – Vol. 54 (Suppl. 2). – P. 41.
54. Airway pathogens during the first year after lung transplantation: a singlecenter experience / Z. Kovats [et al.] // Transplant. Proc. – 2011. – Vol. 43 (4). – P. 1290–1291.
55. Trends in invasive disease due to Candida species following heart and lung transplantation / J. M. Schaenman [et al.] // Transplant. Infect. Dis. – 2009. – Vol. 11 (2). – P. 112–121.
56. Candiduria in renal transplant recipients: incidence, clinical repercussion, and treatment indication / J. Delgado [et al.] // Transplant. Proc. – 2010. – Vol. 42 (8). – P. 2944–2946.
57. Predictors and outcomes of candiduria in renal transplant recipients / N. Safdar [et al.] // Clin. Infect. Dis. – 2005. – Vol. 40 (10). – P. 1413–1421.
58. Kidney transplants from infected donors: our experience / M. Battaglia [et al.] // Transplant. Proc. – 2004. – Vol. 36 (3). – P. 491–492.
59. Caspofungin in the treatment of symptomatic candiduria / J. D. Sobel [et al.] // Clin. Infect. Dis. – 2007. – Vol. 44 (5). – P. E46 – E49.
60. Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit / L. OstroskyZeichner [et al.] // Mycoses. – 2011. – Vol. 54 (1). – P. 46–51.
Рецензия
Для цитирования:
Журавель С.В., Чугунов А.О., Черненькая Т.В. Проблема системного кандидоза после трансплантации солидных органов. Обзор литературы. Трансплантология. 2012;(3):42-48. https://doi.org/10.23873/2074-0506-2012-0-3-42-48
For citation:
Zhuravel S.V., Chugunov A.O., Chernenkaya T.V. The problem of systemic candidosis after transplantation of solid organs. Review of the literature. Transplantologiya. The Russian Journal of Transplantation. 2012;(3):42-48. (In Russ.) https://doi.org/10.23873/2074-0506-2012-0-3-42-48
Просмотров: 450
Послать статью по эл. почте 